Navigation Links
Bilcare Signs Pact With Honeywell for Packaging Solutions

Mumbai: Bilcare, a leading research-based pharmaceutical packing solution company, Tuesday announced a regional development collaboration with Honeywell//, a UK-based pharma packaging firm, to provide high-barrier packaging solution for the pharmaceutical sector.

"The partnership with Honeywell's Healthcare Film Business would help Bilcare to provide state-of-the-art materials for ensuing safety of sensitive drugs," said Mohan Bhandari, chairman and managing director of Bilcare, at a news conference here Tuesday.

"It will generate application-based packaging system for the pharmaceutical sector," he added.

Rick Knight, Honeywell's global business manager, said the partnership would develop new application for the company's 'Aclar' high barrier material specifically designed for pharmaceuticals.

Knight said the partnership would help address some of the challenges faced by the pharmaceutical industry, including counterfeit drugs, lack of effective packaging for providing adequate protection to drugs for retaining efficacy and potency throughout their shelf life and accidental misuse of drugs.

Source-IANS
'"/>




Page: 1

Related medicine news :

1. Recognize Heart Attack Signs
2. Parents Should Look For Signs Of Children Becoming Overweight
3. Early Warning Signs Of Heart Disease
4. Warning Signs On Powered Baby Milk
5. Genetical Screening Can Detect Early Signs Of Multiple Sclerosis
6. MIOT Hospital Signs Agreement With German Healthcare Facility
7. Blue Cross Signs Up 110,000 Minnesotans For Part D Medicare Plans
8. Teenager Shows Signs Of Recovery after Receiving Massive Dose of Radiation
9. Ramdev Signs MOU With Jharkhand Govt To Set Up Ayurveda Hospital
10. Visual Signs Attuned To Reading Rather Than Writing
11. Complaints Of Memory Loss Could Be Signs Of Alzheimers disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2016)... ... December 05, 2016 , ... The Avamere Family ... – Avamere Transitional Care of Puget Sound ; located at 630 S ... center will provide patients recovering from illness or injury with intensive skilled nursing ...
(Date:12/5/2016)... (PRWEB) , ... December 05, 2016 , ... Researchers at ... on the growing brains of young athletes. Over the course of three years, researchers ... through unique mouth guards. The mouth guards, equipped with special sensors, will track the ...
(Date:12/5/2016)... Fla (PRWEB) , ... December 05, 2016 , ... ... as Keynote speaker for the 21st Annual International Congress on Hematologic Malignancies®: Focus ... announcement, PER® president, Phil Talamo said, “We are honored to have Amy E. ...
(Date:12/5/2016)... ... December 05, 2016 , ... Dr. Barry M. Weintraub, one of New York ... participated in the 36th Annual Cutting Edge Aesthetic Symposium at the Waldorf Astoria in ... that perfect, yet natural-looking, nose. Dr. Weintraub, who is world-renowned for his expertise in ...
(Date:12/5/2016)... and MALVERN, PA (PRWEB) , ... ... ... Supplies Management ("CSM"), a Great Point Partners ("GPP") portfolio company, today announced ... – Clinical Supplies ("TCS"). TCS was previously a subsidiary of Chiltern ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... -- Sanovas, Inc., a life science asset holding ... its wholly owned subsidiary, Intubation Science, Inc., and its LightSpeed ... - http://photos.prnewswire.com/prnh/20161202/445251LOGO   ... Sanovas, Inc. ... There are over 40 million Endotracheal Intubations performed ...
(Date:12/5/2016)... 2016  CVS Health, the nation,s largest pharmacy innovation ... score of 100 percent on the Corporate Equality Index ... an annual national benchmarking survey and report on corporate ... the Human Rights Campaign Foundation. "Our ... colleagues, customers and suppliers bring to CVS Health," said ...
(Date:12/5/2016)... PARSIPPANY, N.J. , Dec. 5, 2016 /PRNewswire/ ... announced preliminary safety and efficacy data from a ... selective MDM2 inhibitor, suggesting that DS-3032 may be ... acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome ... of the phase 1 study of DS-3032 were presented ...
Breaking Medicine Technology: